Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
Alessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò, Marco Frigeni, Gianmaria Borleri, Anna Salvi, Francesco Landi, Chiara Pavoni, Aurelio Sonzogni, Andrea Gianatti, Francesca Binda, S. Fagiuoli, Fabiano Di Marco, Ferdinando Luca Lorini, Giuseppe Remuzzi, Steve Whitaker, Gregory Demopulos
Topics & Concepts
Lectin pathwayARDSMedicineComplement systemImmunologyThrombotic microangiopathyEndothelial activationGastroenterologyInternal medicineInflammationPharmacologyAlternative complement pathwayLungAntibodyDiseaseCOVID-19 Clinical Research StudiesComplement system in diseasesSARS-CoV-2 and COVID-19 Research